New Delhi: Glenmark Pharmaceuticals today said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19. The Mumbai-based drug firm had…
New Delhi: Glenmark Pharmaceuticals today said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19.
The Mumbai-based drug firm had on Friday received manufacturing and marketing approval from the Drugs Controller General of India (DCGI). FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the company said in a statement.
Karnataka Housing Board earmarks 1,900 acres near Bommanahalli in Yelwal hobli Submits proposal to State Govt. seeking land notification Mysuru: Amidst the ongoing Bidadi Township row where the farmers have been protesting…
Mysuru: Maintaining that Mysuru Development Authority (MDA) has been left orphaned by the Government with the non-appointment of a regular Commissioner, BJP MLC Raghu Kautilya alleged that the MDA has been virtually…
Mysuru: The State Government should name Suttur Mutt Seer Sri Shivarathri Deshikendra Swamiji to inaugurate Dasara-2026 atop Chamundi Hill on Oct. 11, said BJP MLC Raghu Kautilya. Addressing a press meet at…
